Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coproporphyrinogen-III oxidase (CPOX) is a mitochondrial enzyme that catalyzes the sixth step in heme biosynthesis: the oxidative decarboxylation of coproporphyrinogen III to protoporphyrinogen IX[1][2]. The enzyme is encoded by the CPOX gene and primarily expressed in the liver, bone marrow, and blood, where heme production is critical[1][2]. Deficiency of CPOX activity due to genetic mutations results in hereditary coproporphyria, an acute hepatic porphyria characterized by episodes of abdominal pain, neuropsychiatric symptoms, and/or photosensitivity[3]. CPOX is a homodimeric protein localized to the mitochondrial intermembrane space and is unique among oxidases in performing its reactions in a metal- and cofactor-independent manner[3]. Its function is essential for the biosynthesis of hemoproteins including hemoglobin, myoglobin, and cytochromes[1][2].
Enzyme replacement or substrate reduction (not direct but disease management: heme arginate provides heme to downregulate endogenous biosynthesis and alleviate symptoms in porphyria attacks)[3]
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coproporphyrinogen-III oxidase, mitochondrial (CPOX).